Frankincense

Boswellia serrata

Common & Folk Names

• Indian Frankincense
• Salai Guggul
• Sallaki
• Olibanum
• Indian Olibanum
• Boswellia Gum
• Incense Tree
• Dhoop

Plant Family

Burseraceae—The Torchwood family

Geographic Location

Frankincense is native to the Indian subcontinent, particularly the dry tropical regions of India including Madhya Pradesh, Gujarat, Rajasthan, Uttar Pradesh, Maharashtra, Andhra Pradesh, and Jharkhand. The species also extends to Pakistan, Bangladesh, and Sri Lanka. Related Boswellia species (B. sacra, B. carteri, B. frereana, B. papyrifera) are found throughout the Middle East, North Africa, Somalia, Yemen, and Oman.

Habitat

Boswellia serrata characteristically inhabits tropical dry deciduous forests and occurs in very dry teak forests or dry mixed deciduous forests. It is commonly found on slopes and ridges of rocky hills, as well as on flat terrain, growing in association with species such as Terminalia spp., Anogeissus latifolia, and Acacia leucophloea. The tree thrives in harsh, arid scrublands and rocky hillsides where it forms part of the understory or mid-canopy in semi-arid ecosystems.

Growing Conditions

Sun: Requires full sun for optimal growth and resin production

Temperature: Grows best at 33-42°C, tolerates 0-45°C; mature plants can be killed at -2°C or lower

Rainfall: Prefers 1,000-1,500mm annually but tolerates 500-2,000mm; requires distinct dry season

Altitude: Typically found from 100 to 1,150 metres above sea level

Soil: Grows on well-drained, calcareous soils including sandy-loam, gravelly, or rocky substrates derived from limestone, gneiss, schist, sandstone, or quartzite; pH range 6.5-8.0; tolerates nutrient-poor, shallow soils

Propagation: Grown from seed, though natural viability is low (20-30%); mechanical scarification can increase germination to 68%; seeds germinate in 2-4 weeks under moist monsoon conditions; can also produce root suckers

Care: Drought-resistant and fire-hardy; frost-tolerant once established; slow-growing (seedlings require 10-12 weeks to reach transplantable size); reaches reproductive maturity in 7-10 years. Note: All Boswellia species are threatened by habitat loss and overharvesting

Harvesting Guidelines

The oleogum resin is harvested by making careful incisions in the bark of the trunk and branches. A milky liquid exudes from these cuts, which coagulates and hardens into amber-coloured “tears” upon exposure to air. These resin tears are then collected by hand. Sustainable harvesting is critical to prevent tree depletion and ensure long-term viability. Trees should be at least 7-10 years old before tapping begins. Excessive tapping can weaken or kill trees, so responsible harvesting practices with adequate rest periods between tappings are essential. The resin contains 15-20% of boswellic, lupeolic, and pentacyclic triterpenic acids.

Parts Used

• Oleogum resin (primary medicinal part)
• Essential oil (distilled from resin)
• Bark (traditional use)

Constituents & their Actions

The therapeutic properties of frankincense arise from a complex mixture of bioactive compounds found in the oleogum resin. These constituents work synergistically to produce profound anti-inflammatory, analgesic, and immunomodulatory effects through multiple biochemical pathways.

Boswellic Acids:

Boswellic acids are pentacyclic triterpene acids unique to the Boswellia genus and represent the primary active constituents, comprising 30% of the resin. These compounds are responsible for frankincense’s potent anti-inflammatory activity through specific enzyme inhibition. Some of the main boswellic acids in frankincense are:

• β-Boswellic acid (BBA)
• 11-Keto-β-boswellic acid (KBBA)
• Acetyl-β-boswellic acid (ABBA)
• Acetyl-11-keto-β-boswellic acid (AKBA) — the most pharmacologically active

The main actions of these boswellic acids are:

• Anti-inflammatory (via 5-lipoxygenase inhibition)
• Anti-arthritic (prevents cartilage degradation)
• Analgesic (pain relief)
• Immunomodulatory (regulates immune response)
• Anti-proliferative (inhibits abnormal cell growth)

Tetracyclic Triterpenic Acids:

These structurally related compounds complement the pentacyclic boswellic acids and contribute additional anti-inflammatory effects. Some of the main tetracyclic triterpenic acids in frankincense are:

• α-Oxotrucallic acid
• 3-Hydroxytirucallic acid
• 3-Acetoxytirucallic acid

The main actions of these tetracyclic triterpenic acids are:

• Anti-inflammatory
• Analgesic
• Support for overall therapeutic efficacy

Volatile Oils:

The essential oil fraction contains aromatic compounds that contribute to frankincense’s antimicrobial, expectorant, and nervine properties. The volatile oil composition includes monoterpenes (13%) and diterpenes (40%), along with various esters and aromatic compounds. Some of the main volatile oil components in frankincense are:

• α-Pinene (major component)
• Limonene
• Myrcene
• Incensole acetate
• Ethyl acetate (21.4%)
• Octyl acetate (13.4%)
• Methylanisole (7.6%)

The main actions of these volatile oils are:

• Antimicrobial (antibacterial and antifungal)
• Anti-inflammatory
• Expectorant (aids respiratory function)
• Bronchodilatory (opens airways)
• Anxiolytic and antidepressant (especially incensole acetate)
• Sedative

Polysaccharides:

Complex sugar molecules that enhance immune function and support tissue healing. These compounds demonstrate immunomodulatory activity and may enhance immune surveillance.

The main actions of these polysaccharides are:

• Immunomodulatory (regulates immune response)
• Supports tissue regeneration
• Anti-inflammatory

Flavonoids and Phenolic Compounds:

Antioxidant compounds that provide additional therapeutic benefits. Some of the flavonoids in frankincense include quercetin and kaempferol, while phenolic compounds include caffeic acid and ferulic acid.

The main actions of these flavonoids and phenolic compounds are:

• Antioxidant (neutralises free radicals)
• Anti-inflammatory
• Vascular protection

Actions with Mechanisms

Anti-inflammatory:
Frankincense produces profound anti-inflammatory effects through multiple complementary pathways. The boswellic acids, particularly AKBA, selectively inhibit the 5-lipoxygenase (5-LOX) enzyme, which in turn blocks the synthesis of pro-inflammatory leukotrienes (especially LTB4) that drive inflammation in conditions like arthritis, asthma, and inflammatory bowel disease. This mechanism is distinct from conventional NSAIDs (which inhibit COX enzymes), allowing frankincense to reduce inflammation without the gastrointestinal side effects common to pharmaceutical anti-inflammatories. Additionally, boswellic acids inhibit the activation of NF-κB, a key transcription factor that regulates the expression of numerous pro-inflammatory genes, which in turn reduces the production of inflammatory cytokines, chemokines, and adhesion molecules throughout multiple tissue systems.

Anti-arthritic and Analgesic:
The anti-arthritic action operates through multiple mechanisms beyond simple inflammation reduction. Boswellic acids inhibit the production of inflammatory leukotrienes in joint tissues, which in turn decreases pain, swelling, morning stiffness, and improves mobility in osteoarthritis and rheumatoid arthritis. Furthermore, these compounds prevent the breakdown of cartilage by inhibiting enzymes like matrix metalloproteinases and elastase that degrade the extracellular matrix of joint cartilage, which in turn provides disease-modifying effects that protect joint structure over time. Clinical studies demonstrate that frankincense can reduce pain scores, increase walking distance, and improve knee flexion comparable to conventional anti-inflammatory medications.

Immunomodulatory:
Frankincense exhibits sophisticated immune regulation rather than simple immune suppression or stimulation. The boswellic acids modulate immune function by inhibiting NF-κB activation in immune cells, which in turn reduces excessive inflammatory responses while preserving necessary immune surveillance. The polysaccharides enhance appropriate immune function, which in turn supports the body’s ability to respond to genuine threats while reducing autoimmune and allergic overreactions. This balanced immunomodulation makes frankincense valuable in both inflammatory autoimmune conditions (where immune dampening is beneficial) and in supporting immune competence during infection or cancer.

Nervine and Anxiolytic:
The volatile oil component incensole acetate produces notable effects on mood and cognition through a unique mechanism. Incensole acetate activates TRPV3 (transient receptor potential vanilloid 3) ion channels in brain regions associated with emotional regulation, which in turn produces anxiolytic and antidepressant-like effects demonstrated in animal studies. This activation influences neurotransmitter systems and promotes a calm, focused mental state, which in turn supports traditional use of frankincense in meditation and spiritual practices. Additionally, frankincense may enhance learning and memory through effects on hippocampal function.

Respiratory Support and Expectorant:
The volatile oils, especially α-pinene, produce direct bronchodilatory effects by relaxing smooth muscle in the airways, which in turn improves airflow in conditions like asthma and bronchitis. The anti-inflammatory effects of boswellic acids reduce airway inflammation and mucus hypersecretion, which in turn decreases the frequency and severity of asthma attacks. The expectorant properties help thin and mobilise bronchial secretions, which in turn facilitates the clearing of congestion from the respiratory tract. Clinical trials show frankincense extract reduces dyspnoea (difficulty breathing), wheezing, and the frequency of asthma attacks.

Gastroprotective and Anti-ulcer:
Frankincense demonstrates protective effects on the gastrointestinal mucosa through multiple pathways. The anti-inflammatory action reduces inflammation in the intestinal lining in conditions like ulcerative colitis and Crohn’s disease, which in turn promotes healing of damaged tissue and reduces symptoms of pain and diarrhoea. Boswellic acids modulate immune responses in the gut-associated lymphoid tissue, which in turn helps restore balance in inflammatory bowel conditions. Animal studies show frankincense protects against ulcer formation and promotes healing through antioxidant effects and reduction of gastric acid secretion.

Neuroprotective:
Emerging research reveals frankincense’s ability to protect nervous system tissue from various forms of injury. Boswellic acids reduce neuroinflammation and oxidative stress in brain tissue, which in turn may slow neurodegenerative processes in conditions like Alzheimer’s disease. The compounds show promise in reducing peritumoral brain oedema (swelling around brain tumours), which in turn improves neurological function in cancer patients. Additionally, frankincense may protect brain tissue from ischemic injury (damage from reduced blood flow) and reduce reperfusion injury when blood flow is restored.

Anti-proliferative and Anti-cancer:
Boswellic acids demonstrate the ability to inhibit abnormal cell proliferation through multiple mechanisms. They inhibit the synthesis of DNA, RNA, and protein in cancer cells in a dose-dependent manner, which in turn slows or stops cancer cell division. The compounds induce apoptosis (programmed cell death) in various cancer cell lines including leukaemia, breast cancer, colon cancer, and brain tumours, which in turn selectively eliminates malignant cells. Frankincense also inhibits angiogenesis (the formation of new blood vessels that feed tumours), which in turn may prevent tumour growth and metastasis. Clinical trials show frankincense extract can reduce tumour cell proliferation in breast cancer patients.

Main Use

Frankincense is primarily employed as a powerful anti-inflammatory and analgesic agent for chronic inflammatory conditions, particularly those affecting the joints, respiratory system, and gastrointestinal tract. Its most extensively researched and clinically validated applications centre on osteoarthritis and rheumatoid arthritis, where it reduces joint pain, swelling, and stiffness while improving mobility and potentially offering disease-modifying effects that protect cartilage from further degradation.

In respiratory medicine, frankincense demonstrates significant benefit in asthma, chronic bronchitis, and other inflammatory airway conditions, reducing bronchospasm, inflammation, and mucus production while improving breathing capacity. For inflammatory bowel diseases including ulcerative colitis and Crohn’s disease, frankincense helps induce remission, heal intestinal mucosa, and reduce inflammatory symptoms with efficacy comparable to conventional pharmaceutical treatments.

Topically, frankincense-infused oils and salves address inflammatory skin conditions including psoriasis, eczema, acne, and wound healing, leveraging its antimicrobial and tissue-regenerative properties. The essential oil is valued in aromatherapy for its anxiolytic and mood-enhancing effects, supporting mental clarity, emotional balance, and meditative states. Emerging applications include neuroprotection (particularly reducing brain oedema in cancer patients), immune modulation in autoimmune conditions, and as an adjunctive therapy in certain cancers, though these uses require further clinical validation.

Preparations

Standardised Extract (Capsules/Tablets): Most clinical research uses standardised extracts containing 30-65% boswellic acids or specifically enriched in AKBA. Commercial products typically contain 300-500mg per capsule. Take 300-500mg 2-3 times daily with food (fatty meals enhance absorption). Look for products standardised to contain at least 10-15 µg/mL AKBA for maximum therapeutic benefit.

Tincture (1:3 to 1:5, 60-70% alcohol): The resin requires high alcohol concentration for proper extraction. Take 2-5mL (40-100 drops) 2-3 times daily in water or juice. Tinctures allow for flexible dosing but may be less standardised than commercial extracts.

Infused Oil (for topical use): Gently warm frankincense resin tears in a carrier oil (such as olive, jojoba, or sweet almond oil) using a double boiler or slow cooker on lowest heat for 4-6 hours. Strain and bottle. Apply to affected joints, muscles, or inflamed skin areas 2-3 times daily. Can be enhanced with addition of frankincense essential oil (2-3% dilution).

Essential Oil (aromatherapy and topical): Steam-distilled from the resin. For aromatherapy: diffuse 3-5 drops or inhale directly from the bottle for respiratory support and mood enhancement. For topical use: dilute 2-3% in carrier oil (approximately 12-18 drops per 30mL carrier oil) and apply to temples for headache, chest for respiratory congestion, or affected areas for inflammation. Never apply undiluted essential oil directly to skin.

Traditional Resin (incense): Burn resin tears on charcoal for aromatic and respiratory benefits. The smoke can be inhaled (at a distance) for traditional spiritual use and mild respiratory support, though this is less precise for medicinal dosing.

Powdered Resin (internal use): In Ayurvedic tradition, the dried resin is ground to powder and taken in doses of 300-900mg 2-3 times daily, often combined with warm water, milk, or honey. This is less common than standardised extracts but remains traditional.

Dosage

Dried Resin Powder: 300-900mg taken 2-3 times daily (900-2,700mg total daily dose)

Standardised Extract (30-65% boswellic acids): 300-500mg taken 2-3 times daily with food (900-1,500mg total daily dose). Clinical studies have safely used up to 1,000mg three times daily (3,000mg total). For AKBA-enriched extracts: 100-250mg daily in divided doses.

Tincture (1:3, 60% alcohol): 2-5mL (40-100 drops) 2-3 times daily

Topical Oil or Salve: Apply to affected areas 2-3 times daily as needed

Essential Oil (topical, diluted): 2-3% dilution in carrier oil (12-18 drops per 30mL); apply to affected areas 2-3 times daily

Essential Oil (aromatherapy): Diffuse 3-5 drops or inhale directly as needed for respiratory or emotional support

Clinical Notes: Fatty meals significantly enhance the bioavailability of boswellic acids when taken orally. Effects are generally observed within 2-8 weeks of consistent use for chronic inflammatory conditions. Treatment duration in clinical studies typically ranges from 6 weeks to 6 months. Longer-term use appears safe based on traditional use and clinical trial data.

Safety & Drug Interactions

Scientific Evidence

Osteoarthritis and Joint Health: Multiple randomised controlled trials demonstrate frankincense’s efficacy in osteoarthritis. A 2003 study in Phytomedicine found that all 30 participants with knee osteoarthritis who received Boswellia serrata extract (333mg three times daily) experienced decreased knee pain, increased knee flexion, and improved walking distance within 8 weeks. Subsequent studies, including systematic reviews and meta-analyses, confirm these findings with AKBA-enriched extracts (100-250mg daily) showing particularly strong results. Frankincense demonstrated benefits comparable to or exceeding some conventional anti-inflammatory medications, with the added advantage of protecting cartilage from degradation. A 2018 placebo-controlled trial combining Boswellia with curcumin showed significant improvements in pain and function scores.

Inflammatory Bowel Disease: Clinical trials in ulcerative colitis and Crohn’s disease show promising results. A 2001 study found that Boswellia serrata gum resin (350mg three times daily for 6 weeks) induced remission in approximately 80% of patients with grade II-III ulcerative colitis, with efficacy comparable to sulfasalazine (a standard pharmaceutical treatment). Another study compared a specialised Boswellia extract (H15) to the prescription anti-inflammatory mesalamine for Crohn’s disease, finding similar effectiveness. While the number of clinical trials remains limited, results consistently support frankincense’s therapeutic potential in inflammatory bowel conditions.

Asthma and Respiratory Conditions: A double-blind, placebo-controlled 6-week study published in European Journal of Medical Research (1998) treated 80 adults with bronchial asthma using Boswellia serrata gum resin (300mg three times daily). Seventy percent of the Boswellia group showed improvement in symptoms including reduced dyspnoea (difficulty breathing), decreased wheezing and rhonchi (abnormal lung sounds), and fewer asthma attacks, compared to only modest improvements in the placebo group. The anti-inflammatory and bronchodilatory mechanisms provide a sound scientific rationale for these clinical observations.

Cancer Research: Emerging clinical evidence supports frankincense’s anti-proliferative effects. A 2024 Phase Ia window of opportunity trial published in Breast Cancer Research and Treatment enrolled patients with invasive breast cancer who took 2,400mg Boswellia serrata extract daily for a median of 11 days before surgery. Results showed a statistically significant 13.8% reduction in tumour cell proliferation (measured by Ki-67 staining) compared to a 54.6% increase in the untreated control group. No serious adverse events occurred. While this is preliminary evidence, it aligns with extensive preclinical research showing anti-proliferative and pro-apoptotic effects in various cancer cell lines including leukaemia, colon cancer, melanoma, and brain tumours.

Brain Oedema: A prospective, randomised, placebo-controlled, double-blind pilot trial published in Cancer (2011) studied patients with brain tumours receiving radiation therapy. Boswellia supplementation reduced peritumoral brain oedema (swelling around tumours) in 60% of patients compared to 26% in placebo, though it did not affect tumour size itself. This effect may improve neurological function and quality of life in brain cancer patients.

Safety and Tolerability: Multiple systematic reviews and long-term clinical trials consistently report excellent safety profiles. Standardised Boswellia serrata extracts in doses up to 1,000mg three times daily (3,000mg total) have been safely used for up to 6 months in clinical trials. Adverse effects, primarily mild gastrointestinal symptoms, occur in less than 15% of participants and are typically less frequent and severe than with conventional NSAIDs. A comprehensive toxicology study in rats using oral doses of 5,000mg/kg found the extract to be safe and non-genotoxic.

Western Energetics

Temperature: Cooling and Drying. Frankincense clears heat from inflamed tissues, making it indicated for “hot” conditions characterised by redness, swelling, pain, and inflammation such as arthritis, inflammatory bowel disease, inflamed airways in asthma, and hot, irritated skin conditions. The drying quality helps resolve excess mucus in respiratory conditions and dampness in the digestive tract.

Moisture: Drying. Its astringent resinous nature helps tighten and tone tissues, making it useful for conditions with excessive secretions including productive coughs with copious phlegm, diarrhoea, and weeping skin conditions. However, this drying quality means it should be used cautiously in individuals with dry constitutions or conditions characterised by dryness.

Tissue State: Primarily indicated for Heat/Excitation states characterised by inflammation, pain, and hyperactive immune responses. Also useful in Damp/Stagnation where inflammation combines with fluid accumulation or poor tissue drainage (such as oedema or lymphatic congestion). The immunomodulatory effects make it valuable in Atrophy/Depression states where immune function requires support, particularly in cancer or chronic degenerative conditions.

Taste

Bitter: The dominant bitter taste relates directly to frankincense’s anti-inflammatory and antimicrobial actions. Bitterness signals the presence of triterpene acids and other compounds that cool inflammation, dry excess secretions, and support detoxification processes. The bitter taste also stimulates digestive secretions when taken internally, supporting traditional use for digestive complaints.

Pungent/Aromatic: The aromatic pungent quality comes from the volatile oil fraction and contributes to frankincense’s expectorant, antimicrobial, and nervine properties. This taste component supports the movement of stagnant energy, clears phlegm from the respiratory tract, and produces the emotionally uplifting and mentally clarifying effects valued in aromatherapy and spiritual practice.

Astringent: A subtle astringent quality relates to frankincense’s resinous nature and its ability to tone and tighten tissues, stop excessive secretions, and promote wound healing. This astringency complements the drying energetic and supports the herb’s vulnerary (wound-healing) applications.

Plant Lore

Frankincense holds one of the longest and most revered histories of any medicinal substance, with archaeological evidence of its use dating back over 5,000 years. The ancient Egyptians imported vast quantities of frankincense from the land of Punt (likely modern-day Somalia), using it in religious ceremonies, embalming practices, and cosmetics. The famous Egyptian queen Hatshepsut sent trading expeditions specifically to obtain frankincense trees, which were so valuable they were depicted in temple reliefs. The Ebers Papyrus, written around 1,500 BCE, records frankincense as a treatment for wounds, infections, and throat ailments.

In the Abrahamic religious traditions, frankincense occupies a position of profound spiritual significance. The Hebrew Bible mentions frankincense (Hebrew: lebonah) extensively, most notably in the books of Exodus and Leviticus where it formed a key component of the sacred incense (ketoret) burned in the Tabernacle and later the Temple in Jerusalem. The recipe for this holy incense was considered so sacred that its unauthorised preparation carried the death penalty. In the Christian tradition, frankincense appears in one of the most famous Biblical narratives: the three wise men presenting gifts to the infant Jesus of gold, frankincense, and myrrh. Each gift carried symbolic meaning — frankincense represented divinity and prayer, its ascending smoke carrying prayers to heaven.

Islamic tradition also holds frankincense in high regard. The Prophet Muhammad reportedly said that Mary, mother of Jesus, used frankincense during her postpartum recovery. Throughout the Islamic world, frankincense has been burned in mosques and homes, and the resin used medicinally for thousands of years. In Oman and Yemen, frankincense remains deeply woven into cultural identity, with traditional ceremonies and social gatherings often featuring frankincense burning.

In Ayurvedic medicine, Boswellia serrata has been used for over 3,000 years under the names salai guggul or sallaki. Classical Ayurvedic texts describe its use for vata and kapha disorders, particularly those involving joint pain (sandhivata), inflammation, and respiratory conditions. It was considered especially valuable for purifying the blood, supporting healthy digestion, and promoting mental clarity — uses that align remarkably well with modern scientific understanding of its anti-inflammatory, immunomodulatory, and neuroprotective effects.

Beyond medicine and religion, frankincense played a crucial role in ancient trade. The “Frankincense Trail” was a network of trade routes connecting southern Arabia to the Mediterranean world, paralleling the famous Silk Road in economic importance. The Kingdom of Saba (biblical Sheba) grew wealthy controlling frankincense trade routes. Roman historian Pliny the Elder noted that frankincense was more valuable than gold in Rome, and strict laws governed its collection and trade. The Arabian Peninsula’s dominance in frankincense production gave the region enormous economic and political power for centuries.

Traditional wisdom surrounding frankincense emphasises its purifying and protective qualities. In many cultures, burning frankincense was believed to cleanse spaces of negative energies, evil spirits, and disease-causing miasmas. This folk belief aligns with frankincense’s genuine antimicrobial properties. Mothers would pass newborn babies through frankincense smoke for protection and blessing. Students and scholars used frankincense to enhance memory and concentration — a practice now supported by research showing cognitive benefits.

The harvesting of frankincense carries its own traditional lore and ritual practices. In Oman and Yemen, tapping the trees follows ancestral methods passed down through generations. The best quality resin comes from trees growing in the harshest conditions, leading to the saying that “frankincense trees thrive on hardship.” The first tapping of the season produces inferior resin that is discarded; the second and third tappings yield the highest quality “tears.” Traditionally, frankincense harvesters would recite prayers and observe periods of ritual purity before beginning their work, honouring the sacred nature of their task.

In modern times, frankincense has experienced a resurgence of interest both in aromatherapy and clinical herbalism. The essential oil has become one of the most popular aromatherapy oils, valued for its grounding, meditative qualities and its ability to support emotional balance and respiratory health. Scientific research validating traditional uses has brought frankincense into integrative oncology, rheumatology, and gastroenterology practices. However, this renewed interest has put enormous pressure on wild Boswellia populations. Conservation efforts are now critical to ensure these ancient trees, which have served humanity for millennia, continue to thrive for future generations.

Additional Information

Conservation Status: All Boswellia species face conservation concerns due to overharvesting and habitat loss. Boswellia sacra (Arabian frankincense) is listed as “near threatened” by the IUCN. Boswellia serrata, while currently listed as “Least Concern” globally, faces regional vulnerability in India. When purchasing frankincense products, seek suppliers committed to sustainable harvesting practices and consider supporting reforestation efforts. Excessive tapping for commercial resin production, combined with climate change, livestock grazing, and habitat fragmentation, threatens the long-term survival of frankincense trees.

Quality Considerations: The therapeutic value of frankincense products varies significantly based on species, geographic origin, harvesting methods, extraction processes, and standardisation. For clinical applications, choose products standardised to contain specific percentages of boswellic acids (30-65%) or enriched in AKBA. The species Boswellia serrata is the most researched for internal medicinal use, while Boswellia sacra and Boswellia carterii are traditionally preferred for aromatherapy. Resin should be amber to pale yellow in colour with a characteristic sweet, woody, slightly citrus aroma. Dark brown or black resin is lower quality.

Synergistic Combinations: Frankincense combines particularly well with turmeric (Curcuma longa) for joint inflammation and inflammatory bowel conditions — this combination has been extensively researched and shows enhanced efficacy compared to either herb alone. The combination with black pepper (Piper nigrum) may enhance absorption of both frankincense and turmeric. For respiratory conditions, frankincense pairs well with ginger (Zingiber officinale) or liquorice (Glycyrrhiza glabra). For topical applications, frankincense blends well with myrrh (Commiphora species), calendula (Calendula officinalis), or lavender (Lavandula spp.) for wound healing and skin inflammation.

Species Differences: While Boswellia serrata is the primary species used in modern clinical research and Ayurvedic medicine, several other Boswellia species produce frankincense with different chemical profiles and traditional uses. Boswellia sacra (also called B. carteri) from Oman and Yemen is considered the finest for aromatherapy and spiritual use. Boswellia frereana from Somalia produces the highest-grade aromatic frankincense. Boswellia papyrifera from Ethiopia and Sudan is the species harvested in biblical lands. Each species has subtle differences in volatile oil composition and boswellic acid content, though all share core anti-inflammatory and aromatic properties.

Storage: Store frankincense resin in a cool, dry, dark place in an airtight container where it will remain stable for several years. Essential oil should be kept in dark glass bottles away from heat and light; properly stored, it remains viable for 2-3 years or longer. Tinctures maintain potency for 3-5 years. Prepared oils should be used within 1 year and checked regularly for rancidity.

Sources

Ammon, H. P. (2010). Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine, 17(11), 862-867.

Ammon, H. P. (2016). Boswellic acids and their role in chronic inflammatory diseases. Advances in Experimental Medicine and Biology, 928, 291-327.

Bannuru, R. R., Osani, M. C., Al-Eid, F., & Wang, C. (2018). Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 48(3), 416-429.

Bone, K., & Mills, S. (2013). Principles and practice of phytotherapy: Modern herbal medicine (2nd ed.). Churchill Livingstone.

Chevallier, A. (1996). The encyclopedia of medicinal plants. DK Publishing.

Efferth, T., & Oesch, F. (2022). Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities. Seminars in Cancer Biology, 80, 39-57.

Grieve, M. (1931). A modern herbal. Jonathan Cape.

Gupta, I., Gupta, V., Parihar, A., Gupta, S., Lüdtke, R., Safayhi, H., & Ammon, H. P. (1998). Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study. European Journal of Medical Research, 3(11), 511-514.

Gupta, I., Parihar, A., Malhotra, P., Singh, G. B., Lüdtke, R., Safayhi, H., & Ammon, H. P. (2001). Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Medica, 67(5), 391-395.

Haroyan, A., Mukuchyan, V., Mkrtchyan, N., Minasyan, N., Gasparyan, S., Sargsyan, A., Narimanyan, M., & Hovhannisyan, A. (2018). Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: A comparative, randomized, double-blind, placebo-controlled study. BMC Complementary and Alternative Medicine, 18(1), 7.

Hoffmann, D. (2003). Medical herbalism: The science and practice of herbal medicine. Healing Arts Press.

Kimmatkar, N., Thawani, V., Hingorani, L., & Khiyani, R. (2003). Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee — A randomized double blind placebo controlled trial. Phytomedicine, 10(1), 3-7.

Kirste, S., Treier, M., Wehrle, S. J., Becker, G., Abdel-Tawab, M., Gerbeth, K., Hug, M. J., Lubrich, B., Grosu, A. L., & Momm, F. (2011). Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: A prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer, 117(16), 3788-3795.

Mills, S., & Bone, K. (2005). The essential guide to herbal safety. Churchill Livingstone.

Mothana, R. A., & Lindequist, U. (2005). Antimicrobial activity of some medicinal plants of the island Soqotra. Journal of Ethnopharmacology, 96(1-2), 177-181.

Siddiqui, M. Z. (2011). Boswellia serrata, a potential antiinflammatory agent: An overview. Indian Journal of Pharmaceutical Sciences, 73(3), 255-261.

Thulin, M. (2020). The genus Boswellia (Burseraceae): The frankincense trees. Symbolae Botanicae Upsalienses 39. Uppsala University.

Valente, I. V. B., Garcia, D., Abbott, A., Spruill, L., Siegel, J., Forcucci, J., Hanna, G., Mukherjee, R., Hamann, M., Hilliard, E., Lockett, M., Cole, D. J., & Klauber-DeMore, N. (2024). The anti-proliferative effects of a frankincense extract in a window of opportunity phase Ia clinical trial for patients with breast cancer. Breast Cancer Research and Treatment, 204(2), 235-244.

van Wyk, B.-E., & Wink, M. (2017). Medicinal plants of the world (2nd ed.). CABI.

Williamson, E. M., Driver, S., & Baxter, K. (Eds.). (2013). Stockley’s herbal medicines interactions. Pharmaceutical Press.

Yu, G., Xiang, W., Zhang, T., Zeng, L., Yang, K., & Li, J. (2020). Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: A systematic review and meta-analysis. BMC Complementary Medicine and Therapies, 20, 225.

---